Insider · CIK 0001615000

NORTHCOTT JOHN

Reports to the SEC for 2 companies · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001615000

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-05-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Commercial Officer	SSale	−4,592 sh	$3.95	−$18.1K	223,210
2022-02-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Commercial Officer	SSale	−4,852 sh	$10.95	−$53.1K	227,802
2021-12-16	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Commercial Officer	AAward	+37.8K sh	—	—	232,654
2021-12-16	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Commercial Officer	AAward	+67.2K sh	—	—	67,150
2021-11-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Commercial Officer	SSale	−6,061 sh	$13.16	−$79.8K	194,854
2021-08-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Commercial Officer	SSale	−6,192 sh	$13.83	−$85.6K	200,915
2021-05-17	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Commercial Officer	SSale	−6,085 sh	$18.30	−$111K	207,107
2021-02-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Commercial Officer	SSale	−15.4K sh	$22.37	−$344K	213,192
2020-12-18	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Commercial Officer	AAward	+28.6K sh	—	—	228,550
2020-12-18	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Commercial Officer	AAward	+51K sh	—	—	51,000
2019-12-02	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Commercial Officer	AAward	+200K sh	—	—	200,000
2019-12-02	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Commercial Officer	AAward	+200K sh	—	—	200,000
2015-03-02	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Marketing, Comm Strategy	MExercise/Conversion	+11.3K sh	—	—	11,250
2015-03-02	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	VP, Marketing, Comm Strategy	FTax Payment	−3,015 sh	$0.94	−$2,834.1	8,235
2015-03-02	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	VP, Marketing, Comm Strategy	MExercise/Conversion	−11.3K sh	—	—	33,750
2015-02-05	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	VP, Marketing, Comm Strategy	AAward	+121K sh	—	—	120,600
2015-02-05	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	VP, Marketing, Comm Strategy	AAward	+482K sh	—	—	482,400

Recent filings

Accepted (ET)
May 174
NORTHCOTT JOHN0001209191-22-029900
SEC(opens sec.gov)
Feb 184
NORTHCOTT JOHN0001209191-22-011437
SEC(opens sec.gov)
Dec 204
NORTHCOTT JOHN0001209191-21-070691
SEC(opens sec.gov)
Nov 174
NORTHCOTT JOHN0001209191-21-065221
SEC(opens sec.gov)
Aug 184
NORTHCOTT JOHN0001209191-21-052385
SEC(opens sec.gov)
May 194
NORTHCOTT JOHN0001209191-21-034186
SEC(opens sec.gov)
Feb 184
NORTHCOTT JOHN0001209191-21-012120
SEC(opens sec.gov)
Dec 224
NORTHCOTT JOHN0001209191-20-064914
SEC(opens sec.gov)
Dec 44
NORTHCOTT JOHN0001209191-19-059174
SEC(opens sec.gov)
Mar 34
LEXICON PHARMACEUTICALS, INC.0001127602-15-009515
SEC(opens sec.gov)
Feb 94
LEXICON PHARMACEUTICALS, INC.0001127602-15-005041
SEC(opens sec.gov)

Companies

Address

8800 TECHNOLOGY FOREST PLACE

THE WOODLANDS, TX, 77381